Search

everythinglearnresearchcommunity

for

Search:↓

Deep learning helps detect skin conditions and is advancing dermatology diagnosis and treatment.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Hormone therapy in transgender individuals can increase acne and affect hair growth and loss.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.

Venous catheterization may help diagnose the cause of female hyperandrogenism when imaging is unclear.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

PCOS in lean women is a serious health condition with implications beyond fertility, affecting metabolism and increasing cardiovascular disease risk.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Hair follicles are important for drug delivery through the skin, but better methods are needed to understand and improve this process.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Many patients at a dermatology clinic had scalp problems, often unrelated to why they visited, suggesting scalp checks should be regular.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

The document concludes that dermatology training and grading scales need to better represent dark-skinned individuals to improve diagnosis and assessment of skin conditions.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Early and aggressive treatment of scarring alopecia is important to prevent further hair follicle damage.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Androgen therapy might help some women with low libido, but it has risks and should be used carefully.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Hair follicles could be used for targeted drug delivery, with liposomal systems showing promise for this method.

Hair follicles could be used to deliver drugs effectively, with the right understanding and methods.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Pregnancy can cause various skin changes and diseases, requiring careful treatment to protect the baby.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Hair growth dysfunction involves various conditions with limited treatment options.